Regardless of the purported reasons of the ADU approval, the FDA tarnished their "reputation" and now cannot be trusted. Although the FDAs history of approvals and re-trials have always been questioned, now that data no longer takes precedent the system breaks and the amyloid removal scenario becomes a plausible reality. Hopefully it is an outlandish scenario for all of our sakes.
Market Data 
Markets 
AI
